Brief: U.S. Patent And Trademark Office Issues Patent Covering An Enhanced Formulation Of Pliaglis®
16/07/2019 12:36
July 16 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* UNITED STATES PATENT AND TRADEMARK OFFICE ISSUES U.S.
PATENT
COVERING AN ENHANCED FORMULATION OF PLIAGLIS®
Source text for Eikon: ID:nPndTWxwa
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium